Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry Disease

RecruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2027

Conditions

Fabry Disease

Interventions

DRUG

Agalsidase beta

The treatment is following local reimbursement criteria and judge by physician

Trial Locations (1)

RECRUITING

Charles Jia-Yin Hou, Taipei

All Listed Sponsors

lead

Mackay Memorial Hospital

OTHER